| Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus AASLD/IDSA HCV Guidance Panel, RT Chung, GL Davis, DM Jensen, ... Hepatology 62 (3), 932-954, 2015 | 830 | 2015 |
| Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the … D Goldberg, IC Ditah, K Saeian, M Lalehzari, A Aronsohn, EC Gorospe, ... Gastroenterology 152 (5), 1090-1099. e1, 2017 | 601 | 2017 |
| Heterogeneous nuclear ribonucleoprotein K is a transcription factor EF Michelotti, GA Michelotti, AI Aronsohn, D Levens Molecular and cellular biology 16 (5), 2350-2360, 1996 | 452 | 1996 |
| Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection AIHCVG Panel Clinical infectious diseases: an official publication of the Infectious …, 2018 | 359 | 2018 |
| The perils of pathogen discovery: origin of a novel parvovirus-like hybrid genome traced to nucleic acid extraction spin columns SN Naccache, AL Greninger, D Lee, LL Coffey, T Phan, A Rein-Weston, ... Journal of virology 87 (22), 11966-11977, 2013 | 262 | 2013 |
| Consequences of perceived stigma among patients with cirrhosis V Vaughn-Sandler, C Sherman, A Aronsohn, ML Volk Digestive diseases and sciences 59, 681-686, 2014 | 125 | 2014 |
| Discovery of a novel human pegivirus in blood associated with hepatitis C virus co-infection MG Berg, D Lee, K Coller, M Frankel, A Aronsohn, K Cheng, K Forberg, ... PLoS pathogens 11 (12), e1005325, 2015 | 105 | 2015 |
| Rifaximin decreases the incidence and severity of acute kidney injury and hepatorenal syndrome in cirrhosis T Dong, A Aronsohn, K Gautham Reddy, HS Te Digestive diseases and sciences 61, 3621-3626, 2016 | 67 | 2016 |
| Screening for zinc deficiency in patients with cirrhosis: when should we start? S Sengupta, K Wroblewski, A Aronsohn, N Reau, KG Reddy, D Jensen, ... Digestive diseases and sciences 60, 3130-3135, 2015 | 61 | 2015 |
| Herbal hepatoxicity from Chinese skullcap: a case report L Yang, A Aronsohn, J Hart, D Jensen World Journal of Hepatology 4 (7), 231, 2012 | 47 | 2012 |
| A systematic approach to patients with jaundice B Gondal, A Aronsohn Seminars in interventional radiology 33 (04), 253-258, 2016 | 43 | 2016 |
| Distributive justice and the arrival of direct-acting antivirals: who should be first in line? A Aronsohn, D Jensen Hepatology 53 (6), 1789-1791, 2011 | 42 | 2011 |
| Long-term outcomes after treatment with interferon and ribavirin in HCV patients A Aronsohn, N Reau Journal of clinical gastroenterology 43 (7), 661-671, 2009 | 40 | 2009 |
| The benefit of paracentesis on hospitalized adults with cirrhosis and ascites JN Gaetano, D Micic, A Aronsohn, G Reddy, H Te, NS Reau, D Jensen Journal of gastroenterology and hepatology 31 (5), 1025-1030, 2016 | 36 | 2016 |
| Barriers to treatment access for chronic hepatitis C virus infection: a case series AJ Millman, B Ntiri-Reid, R Irvin, MH Kaufmann, A Aronsohn, JS Duchin, ... Topics in antiviral medicine 25 (3), 110, 2017 | 30 | 2017 |
| Informed deferral: a moral requirement for entry into the hepatitis C virus treatment warehouse A Aronsohn, D Jensen Hepatology 56 (5), 1591-1592, 2012 | 30 | 2012 |
| Liver transplantation of HCV-viremic donors into HCV-negative recipients in the United States: increasing frequency with profound geographic variation TG Cotter, A Aronsohn, KG Reddy, M Charlton Transplantation 105 (6), 1285-1290, 2021 | 27 | 2021 |
| Hepatitis C Guidance 2023 Update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection D Bhattacharya, A Aronsohn, J Price, V Lo Re III Clinical Infectious Diseases, ciad319, 2023 | 26 | 2023 |
| Decision making in liver transplantation—limited application of the liver donor risk index L Mataya, A Aronsohn, JR Thistlethwaite Jr, L Friedman Ross Liver Transplantation 20 (7), 831-837, 2014 | 25 | 2014 |
| Hepatobiliary manifestations of critically ill and postoperative patients A Aronsohn, D Jensen Clinics in liver disease 15 (1), 183-197, 2011 | 25 | 2011 |
